4.4 Review

Vascular microRNAs

期刊

CURRENT DRUG TARGETS
卷 11, 期 8, 页码 943-949

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138945010791591313

关键词

Angiogenesis; microRNA; endothelial cells; atherosclerosis

资金

  1. European Research Council (ERC) [232932]
  2. Netherlands Scientific Organization (NWO)
  3. excellence cluster cardiopulmonary system (ECCPS)
  4. European Research Council (ERC) [232932] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

MicroRNAs are endogenously expressed small non-coding RNAs that regulate gene expression on the posttranscriptional level. During the last years microRNAs have emerged as key regulators of several physiological and pathophysiological processes in the vascular wall. Endothelial cell functions and angiogenesis are critically regulated by microRNAs such as miR-126 and the miR-17-92 cluster in vitro and in vivo. Tumor angiogenesis is additionally controlled by miR-296 and miR-378. MicroRNAs also regulate smooth muscle cell phenotypes and control neointima formation and atherosclerosis. In this respect, miR-143 and miR-145 have been shown to play a crucial role. In this review, we summarize the role of microRNAs and their target genes in endothelial and smooth muscle cells and discuss their applicability as drug targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据